Acute Myocarditis after Pfizer-BioNTech COVID-19 m-RNA Vaccination
Journal
South East European Journal of Cardiology
Date Issued
2022-11-30
Author(s)
Elena Grueva-Nastevska
Planinka Zafirovska
Elma Kandic
Simona Jovchevska
Oliver Bushljetikj
DOI
https://doi.org/10.3889/seejca.2022.6032
Abstract
BACKGROUND: Prosthetic mechanical valve endocarditis (PVE) can be manifested as early PVE (acquired perioperatively) and late PVE (resulting from infections unrelated to the valve operation). Causes of both are similar but are late PVE are more prone to less virulent microbes. PVE resulting with paravalvular abscess is confirmed through echocardiography (transthoracic or transesophageal), it results with a high mortality rate especially if it is not early recognized.
CASE PRESENTATION: We are presenting a patient with heart failure symptoms caused by PVE after Pfizer-BioNTech coronavirus disease-2019 (COVID-19) m-RNA vaccination.
CONCLUSION: The exact mechanism of myocarditis in young men who received the second dose of mRNA COVID-19 vaccine is not yet known. However, this is a rare complication and most people generally recover quickly requiring only supportive treatment. In contrast, the risk of developing myocarditis from the viral infection is much higher.
CASE PRESENTATION: We are presenting a patient with heart failure symptoms caused by PVE after Pfizer-BioNTech coronavirus disease-2019 (COVID-19) m-RNA vaccination.
CONCLUSION: The exact mechanism of myocarditis in young men who received the second dose of mRNA COVID-19 vaccine is not yet known. However, this is a rare complication and most people generally recover quickly requiring only supportive treatment. In contrast, the risk of developing myocarditis from the viral infection is much higher.
File(s)![Thumbnail Image]()
Loading...
Name
SEEJCA-3(1)-11.pdf
Size
1.51 MB
Format
Adobe PDF
Checksum
(MD5):b8c1bea31c3ce305a4ec4d244a13c62d